Clinical outcomes and COVID-19 treatment during acute illness, by hospitalization status and age group. حسب Chelsea S. Lutz (16001569)

الموضوعات:

Association of knee OA AMVF patients with continuous variables. حسب Izzatul Nadiah Zolkiply (19681460)

الموضوعات:

Association of categorical variables with AMVF status of knee OA patients (n = 76). حسب Izzatul Nadiah Zolkiply (19681460)

الموضوعات:

Multivariable logistic regression analysis on the variables associated with AMVF in knee OA patients (n = 76). حسب Izzatul Nadiah Zolkiply (19681460)

الموضوعات:

Clinico-demographic characteristics of knee OA patients (n = 76). حسب Izzatul Nadiah Zolkiply (19681460)

الموضوعات:

Table 3_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.docx حسب Linda S. Barter (21466916)

Image 2_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg حسب Linda S. Barter (21466916)

Image 1_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg حسب Linda S. Barter (21466916)

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. حسب Annaëlle Le Steunf (19838110)

Treatment of cancer cells with vitamin D3 induced death <i>a.</i> حسب Vidya G. Bettada (22208808)

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. حسب Marc Van Der Hofstadt (1423027)

Patient Example. حسب James M. Friedman (22522150)

الموضوعات:

This is the raw data used for this study. حسب James M. Friedman (22522150)

الموضوعات:

Pre-operative versus post-operative symptoms. حسب James M. Friedman (22522150)

الموضوعات:

Patient Demographics. حسب James M. Friedman (22522150)

الموضوعات:

Diagnostic Criteria for Human Disharmony Loop. حسب James M. Friedman (22522150)

الموضوعات:

Data. حسب Michael C. Payne (2664379)

الموضوعات:

Prevalence of <i>Wb</i> microfilaremia and circulating filarial antigenemia before and after MDA in annual and semiannual intervention areas. حسب Michael C. Payne (2664379)

الموضوعات:

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. حسب Michael C. Payne (2664379)

الموضوعات:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). حسب Michael C. Payne (2664379)

الموضوعات: